Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Teen Retailers' Moody News Sets Downbeat Tone for Stocks
Synta Pharmaceuticals falls 14.8%
Top Analyst Upgrades and Downgrades: AIG, GM, Rite Aid, Synta, Disney and More
Synta Pharmaceuticals shares rise on disclosure of updated plans for cancer drug
Synta Pharmaceuticals' Management Discusses Q4 2013 Results
Synta Pharmaceuticals reports Q4 EPS (31c), consensus (30c)
Synta and QuantumLeap Healthcare Collaborative Announce Selection of Ganetespib for I-SPY 2 TRIAL in Breast Cancer
Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
Synta , QuantumLeap announce selection of Ganetespib for I-SPY2 TRIAL
Report Published: "Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review"
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta